Hepatobiliary Inflammation, Neoplasia, and Argyrophilic Bacteria in a Ferret Colony

Veterinary Pathology

Volumn 39, Issue 2, 2002, Pages 173-179

  Garci A ^a   Erdman, S E ^a   xu, S ^a   Feng, Y ^a   Rogers, A B ^a   Schrenzel, M D ^a   Murphy, J C ^a   Fox, J G ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Argyrophilic bacteria; cholangiocellular carcinoma; cholangiohepatitis; disease; ferrets; hepatobiliary; histopathology; PCR

Indexed keywords

BACTERIAL DNA;

ANIMAL; ANIMAL DISEASE; ANIMAL HEPATITIS; ARTICLE; BILE DUCT; BILE DUCT CARCINOMA; BILE DUCT TUMOR; BILIARY TRACT DISEASE; CYSTADENOMA; FEMALE; FERRET; GENETICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; LIVER; LIVER DISEASE; MALE; MICROBIOLOGY; PATHOLOGY; POLYMERASE CHAIN REACTION;

ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS; BILIARY TRACT DISEASES; CHOLANGIOCARCINOMA; CYSTADENOMA; DNA, BACTERIAL; FEMALE; FERRETS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEPATITIS, ANIMAL; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LIVER; LIVER DISEASES; MALE; POLYMERASE CHAIN REACTION;

EID: 0036491589     PISSN: 03009858     EISSN: 15444221     Source Type: Journal    
DOI: 10.1354/vp.39-2-173     Document Type: Article

References (42)

1. Ball SM, Whitney RC: What is your diagnosis: hepatic mass involving the left liver lobes. J Am Vet Med Assoc 213: 1707–1708, 1998
2. Batchelder MA, Bell JA, Erdman SE, Marini RP, Murphy JC, Fox JG: Pregnancy toxemia in the European ferret (Mustela putorius furo). Lab Anim Sci 49: 372–379, 1999
3. Bergkist A, Glaumann H, Persson B, Broome U: Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 27: 311–316, 1998
4. Boberg KM, Schrumpf E, Bergquist A, Broome U, Pares A, Remotti H, Schjolberg A, Spurkland A, Clausen OP: Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in neoplastic development. J. Hepatol 32: 374–380, 2000
5. Chalasani N, Baluyut A, Ismail A, Zaman A, Sood G, Ghalib R, McCashland TM, Reddy KR, Zervos X, Anbari MA, Hoen H: Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology 31: 7–11, 2000
6. Crosby HA, Hubscher S, Fabris L, Joplin R, Sell S, Kelly D, Strain AJ: Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6. Am J Pathol 152: 771–779, 1998
7. Cross BM: Hepatic vascular neoplasms in a colony of ferrets. Vet Pathol 24: 94–96, 1987
8. Daoust PY, Hunter DB: Spontaneous Aleutian disease in ferrets. Can Vet J 19: 133–135, 1978
9. Dewhirst FE, Chien CC, Paster BJ, Paster RL, Orcutt R, Schauer DB, Fox JG: Phylogeny of the defined murine microbiota: altered Schaedler flora. Appl Environ Microbiol 65: 3287–3292, 1999
10. Durando MM, MacKay RJ, Staller GS, Cooper BJ, Ginn PE, Meneghetti N: Septic cholangiohepatitis and cholangiocarcinoma in a horse. J Am Vet Med Assoc 206: 1018–1021, 1995
11. Erdman SE, Kanki PJ, Moore FM, Brown SA, Kawasaki TA, Mikule KW, Travers KU, Badylak SF, Fox JG: Clusters of lymphoma in ferrets. Cancer Invest 14: 225–230, 1996
12. Erdman SE, Reimann KA, Moore FM, Kanki PJ, Yu Q, Fox JG: Transmission of a chronic lymphoproliferative syndrome in ferrets. Lab Invest 72: 1–8, 1995
13. Fox JG: Aleutian disease, hepatocellular neoplasms. In: Biology and Diseases of the Ferret, ed. Fox JG, 2nd ed., pp. 360–366, 422–425. Williams and Wilkins, Baltimore, MD, 1998
14. Fox JG: Enterohepatic helicobacters: natural and experimental models. Ital J Gastroenterol Hepatol 30(Suppl 3): 264–269, 1998
15. Fox JG, Dewhirst FE, Shen Z, Feng Y, Taylor NS, Paster BJ, Ericson RL, Lau CN, Correa P, Araya JC, Roa I: Hepatic helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 114: 755–763, 1998
16. Fox JG, Dewhirst FE, Tully JG, Paster BJ, Yan L, Taylor NS, Collins MJ Jr, Gorelick PL, Ward JM: Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J Clin Microbiol 32: 1238–1245, 1994
17. Fox JG, Li X, Murphy JC: Serous biliary cystadenoma in ferrets (Mustela putorius furo). Contemp Top Lab Anim Sci 35: 78–79, 1996
18. Fox JG, Li X, Yan L, Cahill RJ, Hurley R, Lewis R, Murphy JC: Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis. Infect Immun 64: 1548–1558, 1996
19. Fox JG, Paster BJ, Dewhirst FE, Taylor NS, Yan L, Macuch PJ, Chmura LM: Helicobacter mustelae isolation from feces of ferrets: evidence to support fecal-oral transmission of a gastric helicobacter. Infect Immun 60: 606–611, 1992
20. Franklin CL, Beckwith CS, Livingston RS, Riley LK, Gibson SV, Besch-Willifod CL, Hook RR: Isolation of a novel Helicobacter species, Helicobacter cholecystus sp. nov., from the gallbladders of Syrian hamsters with cholangiofibrosis and centrilobular pancreatitis. J Clin Microbiol 34: 2952–2958, 1996
21. Go MF, Smoot DT: Helicobacter pylori, gastric MALT lymphoma, and adenocarcinoma of the stomach. Semin Gastrointest Dis 11: 134–141, 2000
22. Hailey JR, Haseman KJ, Bucher JR, Radovsky AE, Malarkey DE, Miller RT, Nyska A, Maronpot RR: Impact of Helicobacter hepaticus infection in B6C3F1 mice from twelve National Toxicology Program two-year carcinogenesis studies. Toxicol Pathol 26: 602–611, 1998
23. Harada K, Ozaki S, Kono N, Tsuneyama K, Katayanagi K, Hiramatsu K, Nakanuma Y: Frequent molecular identification of Campylobacter but not Helicobacter genus in bile and biliary epithelium in hepatolithiasis. J Pathol 193: 218–223, 2001
24. Ihrig M, Schrenzel MD, Fox JG: Differential susceptibility to hepatic inflammation and proliferation in AXB recombinant inbred mice chronically infected with Helicobacter hepaticus. Am J Pathol 155: 571–582, 1999
25. Kato M, Higuchi T, Orita Y, Ishikawa Y, Kadota K: Combined hepatocellular carcinoma and cholangiocarcinoma in a mare. J Comp Pathol 116: 409–413, 1997
26. Kita E, Nishikawa F, Kamikaidou K, Nakano A, Katsui N, Kashiba S: Mononuclear cell response in the liver of mice infected with hepatotoxigenic Campylobacter jejuni. J Med Microbiol 37: 326–331, 1992
27. Knight B, Yeoh GC, Husk KL, Ly T, Abraham LJ, Yu C, Rhim JA, Fausto N: Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med 192: 1809–1818, 2000
28. Lawrence HJ, Erb HN, Harvey HJ: Nonlymphomatous hepatobiliary masses in cats: 41 cases (1972–1991). Vet Surg 23: 365–368, 1994
29. Lawson GH, Gebhart CJ: Proliferative enteropathy. J Comp Pathol 122: 77–100, 2000
30. Lee JH, Rim HJ, Sell S: Heterogeneity of the “oval cell” response in the hamster liver during cholangiocarcinogenesis following Clonorchis sinensis infection and dimethylnitrosamine treatment. J Hepatol 26: 1313–1323, 1997
31. Li X, Fox JG, Padrid PA: Neoplastic diseases in ferrets: 574 cases (1968–1997). J Am Vet Med Assoc 212: 1402–1406, 1998
32. Li X, Fox JG, Whary MT, Yan L, Shames B, Zhao Z: SCID/NCr mice naturally infected with Helicobacter hepaticus develop progressive hepatitis, proliferative typhilis, and colitis. Infect Immun 66: 5477–5484, 1998
33. Lofstedt J, Schelling S, Stowater J, Morris E: Antemortem diagnosis of hepatic adenocarcinoma in a ewe. J Am Vet Med Assoc 193: 1537–1538, 1988
34. Lowes KN, Brennan BA, Yeoh GC, Olynyk JK: Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol 154: 537–541, 1999
35. Matsusaka S, Toyosaka A, Nakasho K, Tsujimura T, Sugihara A, Takanashi T, Uematsu K, Terrada N, Okamoto E: The role of oval cells in rat hepatocyte transplantation. Transplantation 70: 441–446, 2000
36. McOrist S, Boid R, Lawson GH: Antigenic analysis of Campylobacter species and an intracellular-like organism associated with porcine proliferative enteropathies. Infect Immun 57: 957–962, 1989
37. Ruch RJ, Trosko JE: The role of oval cells and gap junctional intercellular communication in hepatocarcinogenesis. Anticancer Res 19: 4831–4832, 1999
38. Shimonishi T, Sasaki M, Nakanuma Y: Precancerous lesions of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 7: 542–550, 2000
39. Shomer NH, Dangler CA, Schrenzel MD, Whary MT, Paster BJ, Dewhirst FE, Fox JG: Cholangiohepatitis and inflammatory bowel disease (IBD) induced by a novel urease-negative Helicobacter species in A/J and Tac: ICR:Hascid mice. Exp Biol Med 226: 420–428, 2001
40. Tennant BC: Animal models of hepadnavirus-associated hepatocellular carcinoma. Clin Liver Dis 5: 43–68, 2001
41. Ward JM, Anver MR, Haines DC, Benveniste RE: Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am J Pathol 145: 959–968, 1994
42. Yu MC, Yuan JM, Govindarajan S, Ross RK: Epidemiology of hepatocellular carcinoma. Can J Gastroenterol 14: 703–709, 2000